Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Pharmacyclics
Scientific Title
Phase 2 Study of the Combination of Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma